OFFICIALS LEGISLATION INTEREST GROUPS PUBLIC STATEMENTS COMMITTEES VETOES

Senators Warren, King and Representative Doggett Seek Answers from HHS and Commerce on Interagency Working Group for Bayh-Dole

Press Release

Date: June 9, 2023
Location: Washington, D.C.
Issues: Executive Branch Health and Health Care

"We are pleased that the Working Group will consider price in its evaluation of the Administration's march-in authority, but we are concerned that there have been no public updates about the Working Group's membership, process, timeline, or scope of work in the more than two months since it was first announced.

BREAK IN TRANSCRIPT

Though this represents critical progress, more must be done to curb excessive drug prices, including for the more than 200 million Americans who are not on Medicare. The Biden Administration can use its existing authority to step in on behalf of all Americans and rectify pharmaceutical industry abuses that have allowed drug prices to skyrocket, and it can do so without waiting for permission from Congress.

BREAK IN TRANSCRIPT

We support President Biden's goal of lowering drug prices for Americans, and if adopted, we believe these principles will allow the Working Group to fully and independently study these authorities."


Source
arrow_upward